EverSource Wealth Advisors’s Fennec Pharmaceuticals FENC Stock Holding History

EverSource Wealth Advisors’s Portfolio FENC Stock Details FENC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$2.02K	Buy	188 +8	+4%	+$65	﹤0.01%	3716
2026 Q1	$1.11K	Buy	180 +45	+33%	+$347	﹤0.01%	3821
2025 Q4	$1.04K	Hold	135	–	–	﹤0.01%	3701
2025 Q3	$1.26K	Hold	135	–	–	﹤0.01%	3686
2025 Q2	$1.12K	Sell	135 -394	-74%	-$2.69K	﹤0.01%	3702
2025 Q1	$3.22K	Sell	529 -163	-24%	-$1.05K	﹤0.01%	2704
2024 Q4	$4.37K	Buy	+692	New	+$3.54K	﹤0.01%	2412

Other funds holding FENC

Cornerstone Capital Palo Alto, California $1.12B AUM 28.84% 1-Year Est. Return

HFM

Hartford Financial Management Hartford, Connecticut $448M AUM 32.11% 1-Year Est. Return

Eleva Capital Paris, France $343M AUM

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

PFSRSONJ

Police & Firemen's Retirement System of New Jersey Trenton, New Jersey $13.3B AUM 45.46% 1-Year Est. Return

New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return

SOADOR

State of Alaska Department of Revenue Juneau, Alaska $10.1B AUM 42.83% 1-Year Est. Return

STRS Ohio Columbus, Ohio $26.7B AUM 43.32% 1-Year Est. Return

MPWT

MassMutual Private Wealth & Trust Windsor, Connecticut $3.87B AUM 24.64% 1-Year Est. Return

GAMMA Investing Foster City, California $2.69B AUM 42.78% 1-Year Est. Return

EverSource Wealth Advisors's FENC Position: Q2 2026 in Review

EverSource Wealth Advisors increased its Fennec Pharmaceuticals (FENC) stake by 4.4% in Q2 2026, buying an estimated $65 and bringing the position to 188 shares worth $2.02K. The position accounts for ﹤0.01% of the portfolio, ranked #3716.

EverSource Wealth Advisors first reported a position in FENC in Q4 2024 and has held it in 7 quarters since. The position peaked at $4.37K in Q4 2024. 22 funds tracked by Wall St. Rank hold FENC as of Q2 2026.

EverSource Wealth Advisors held 188 shares of Fennec Pharmaceuticals worth $2.02K as of Q2 2026.
EverSource Wealth Advisors bought 8 Fennec Pharmaceuticals shares in Q2 2026, an estimated $65.
Fennec Pharmaceuticals made up ﹤0.01% of EverSource Wealth Advisors's portfolio in Q2 2026, its #3716 holding.
EverSource Wealth Advisors first reported a position in Fennec Pharmaceuticals in Q4 2024 and has held it in 7 quarters since.
EverSource Wealth Advisors's Fennec Pharmaceuticals position peaked at $4.37K in Q4 2024.
22 funds tracked by Wall St. Rank held Fennec Pharmaceuticals as of Q2 2026.

Based on EverSource Wealth Advisors's 13F filing for Q2 2026, filed 24 Jul 2026.